Cargando…

Eligibility of sodium–glucose co‐transporter‐2 inhibitors among patients with diabetes mellitus admitted for heart failure

AIMS: Sodium–glucose co‐transporter (SGLT)‐2 inhibitors have been shown to reduce the risk of cardiovascular death and heart failure (HF) hospitalization in patients with type 2 diabetes mellitus (DM) and high cardiovascular risk in two large clinical outcome trials: empagliflozin in EMPA‐REG OUTCOM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Abhinav, Wu, Jingjing, Ezekowitz, Justin A., Felker, Gary Michael, Udell, Jacob A., Heidenreich, Paul A., Fonarow, Gregg C., Mahaffey, Kenneth W., Hernandez, Adrian F., DeVore, Adam D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083448/ https://www.ncbi.nlm.nih.gov/pubmed/31747132 http://dx.doi.org/10.1002/ehf2.12528

Ejemplares similares

Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus
por: Sharma, Abhinav, et al.
Publicado: (2020)

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure
por: Kelly, Jacob P., et al.
Publicado: (2019)

Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines—Heart Failure
por: Selvaraj, Senthil, et al.
Publicado: (2018)

Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors
por: Angelini, Gianmarco, et al.
Publicado: (2021)

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction
por: Harrington, Josephine, et al.
Publicado: (2023)

Middle-aged female with blue nails and graying skin
por: DeVore, Ansley, et al.
Publicado: (2023)

Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
por: Gilstrap, Lauren G., et al.
Publicado: (2017)

Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease
por: Cooper, Lauren B., et al.
Publicado: (2017)

Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines–Heart Failure Registry
por: Cunningham, Luke C., et al.
Publicado: (2021)

Timing of Postdischarge Follow‐Up and Medication Adherence Among Patients With Heart Failure
por: Chang, Leslie L., et al.
Publicado: (2018)

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
por: Usman, Muhammad Shariq, et al.
Publicado: (2022)

Multiscale, Nonlinear and Adaptive Approximation
por: DeVore, Ronald A
Publicado: (2009)

The approximation of continuous functions by positive linear operators
por: DeVore, Ronald A
Publicado: (1972)

Aquagenic palmoplantar keratoderma therapeutic response to topical glycopyrronium
por: Medhus, Emily J., et al.
Publicado: (2021)

So Much to Say on the Best of What's Around Regarding Sodium‐Glucose Cotransporter‐2 Inhibitors in Acute Myocardial Infarction
por: Nunes, Jairo T., et al.
Publicado: (2023)

Practical problems in mathematics for heating and cooling technicians
por: DeVore, Russell
Publicado: (1998)

Instructor's guide to accompany practical problems in mathematics for heating & cooling technicians
por: DeVore, Russell
Publicado: (1998)

From sharecropping to equal shares: transforming the sharing economy in northeastern Brazil
por: DeVore, Jonathan
Publicado: (2020)

Prescribing patterns and factors associated with sodium–glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Ozaki, Aya F., et al.
Publicado: (2023)

Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure
por: Luo, Nancy, et al.
Publicado: (2019)

Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial
por: Sharma, Abhinav, et al.
Publicado: (2018)

Maximal functions measuring smoothness
por: DeVore, Ronald A, et al.
Publicado: (1984)

Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World)
por: Udell, Jacob A., et al.
Publicado: (2018)

In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization
por: DeVore, Adam D., et al.
Publicado: (2014)

Constructive approximation: fractal approximation
por: DeVore, Ronald, et al.
Publicado: (1989)

Paradoxical Association of Smoking With In‐Hospital Mortality Among Patients Admitted With Acute Ischemic Stroke
por: Ali, Syed F., et al.
Publicado: (2013)

Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy
por: Feng, Kent Y., et al.
Publicado: (2019)

Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT‐HF risk model
por: DeVore, Adam D., et al.
Publicado: (2021)

Eligibility of patients with type 2 diabetes for sodium‐glucose co‐transporter‐2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry
por: Wittbrodt, Eric, et al.
Publicado: (2019)

Probing Structural Perturbation of Biomolecules by Extracting Cryo-EM Data Heterogeneity
por: DeVore, Kira, et al.
Publicado: (2022)

New Strategies to Prevent Rehospitalizations for Heart Failure
por: Diamond, Jamie, et al.
Publicado: (2022)

A novel strategy for the treatment of diabetes mellitus - sodium glucose co-transport inhibitors
por: Niazi, Asfandyar Khan, et al.
Publicado: (2010)

Carbon Monoxide Poisoning With Concomitant Mucosal Injury and Chemical Pneumonitis Using Sulfuric and Formic Acids in a Self-Harm Attempt
por: Lewis, Nicholas, et al.
Publicado: (2021)

Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters
por: Armour, Sarah L., et al.
Publicado: (2022)

Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP‐HF
por: Chapman, Brittany, et al.
Publicado: (2022)

The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus
por: Brunton, S. A.
Publicado: (2015)

Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
por: Carnicelli, Anthony P., et al.
Publicado: (2021)

CYTOCHROME P450 17A1 STRUCTURES WITH PROSTATE CANCER DRUGS ABIRATERONE AND TOK-001
por: DeVore, Natasha M., et al.
Publicado: (2012)

Oral ulcerations in an immunosuppressed pediatric patient
por: DeVore, Ansley, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_puesk53ktadn8j8oogeqa5jsnb